3A Research CEO Andy Silverman, PhD, recently spoke with KXAN News about SURPASS, a new federal initiative announced in Austin aimed at making clinical trials faster, more efficient, and less burdensome for patients.
Drawing on more than 30 years of experience in clinical research and drug development, Silverman discussed opportunities to modernize clinical trials while emphasizing the importance of maintaining rigorous scientific standards and protecting patient safety.
Read the full KXAN News coverage: Robert F. Kennedy Jr. unveils partnership with UT Austin to shorten clinical trials
Video and news coverage courtesy of KXAN.